Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma

Poon, 2011, Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge, Hepatology, 54, 757, 10.1002/hep.24569 Llovet, 2005, Resection and liver transplantation for hepatocellular carcinoma, Semin Liver Dis, 25, 181, 10.1055/s-2005-871198 Qin, 2004, Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature, J Cancer Res Clin Oncol, 130, 497, 10.1007/s00432-004-0572-9 Letsas, 2006, Surfing on prothymosin alpha proliferation and anti-apoptotic properties, Neoplasma, 53, 92 Jiang, 2003, Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway, Science, 299, 223, 10.1126/science.1076807 Magdalena, 2000, Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer, Br J Cancer, 82, 584, 10.1054/bjoc.1999.0968 Sasaki, 2001, Expression of the prothymosin-α gene as a prognostic factor in lung cancer, Surg Today, 31, 936, 10.1007/s005950170040 Sasaki, 2001, Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma, Cancer Lett, 168, 191, 10.1016/S0304-3835(01)00540-7 Leys, 2007, Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer, Surgery, 141, 41, 10.1016/j.surg.2006.05.009 Tsai, 2009, Aberrant prothymosin-alpha expression in human bladder cancer, Urology, 73, 188, 10.1016/j.urology.2008.05.031 Jou, 2009, Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinoma, Urology, 74, 951, 10.1016/j.urology.2008.11.060 Suzuki, 2006, Expression of prothymosin alpha is correlated with development and progression in human prostate cancers, Prostate, 66, 463, 10.1002/pros.20385 Tzai, 2006, Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer, Urology, 67, 294, 10.1016/j.urology.2005.08.034 Wu, 1997, Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma, Br J Cancer, 76, 1199, 10.1038/bjc.1997.533 Edmondson, 1954, Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies, Cancer, 7, 462, 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E Kumada, 1997, Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma, Hepatology, 25, 87, 10.1002/hep.510250116 Edge, 2010 Llovet, 1999, Prognosis of hepatocellular carcinoma: the BCLC staging classification, Semin Liver Dis, 19, 329, 10.1055/s-2007-1007122 Shimada, 2001, Characteristics of multicentric hepatocellular carcinomas: comparison with intrahepatic metastasis, World J Surg, 25, 991, 10.1007/s00268-001-0068-6 Imamura, 2003, Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy, J Hepatol, 38, 200, 10.1016/S0168-8278(02)00360-4 Ahn, 2013, Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma, Hepatobiliary Pancreat Dis Int, 12, 286, 10.1016/S1499-3872(13)60046-6 Gaubatz, 1994, An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc, Mol Cell Biol, 14, 3853, 10.1128/MCB.14.6.3853 Gan, 1993, Analysis of ODC and c-myc gene expression in hepatocellular carcinoma by in situ hybridization and immunohistochemistry, J Histochem Cytochem, 41, 1185, 10.1177/41.8.7687263 Poon, 2000, Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma, Cancer, 89, 500, 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O Kim, 2007, PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection, Oncology, 72, 52, 10.1159/000111707